Evening versus morning dosing regimen drug therapy for hypertension (Q24236288)

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Treatment of non-dipper hypertension with bedtime administration of valsartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Reduction of morning blood pressure surge after treatment with nifedipine GITS at bedtime, but not upon awakening, in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Comparison of a chronotherapeutically administered beta blocker vs. a traditionally administered beta blocker in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

The effect of food, time of dosing, and body position on the pharmacokinetics and pharmacodynamics of verapamil and norverapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Administration time-dependent effects of aspirin on blood pressure in untreated hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

The antihypertensive efficacy and safety of a chronotherapeutic formulation of propranolol in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Duration of effect of single daily dose methyldopa therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Antihypertensive efficacy of night-time graded-release diltiazem versus morning amlodipine in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Chronotherapy of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Chronotherapy in hypertensive patients: administration-time dependent effects of treatment on blood pressure regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Optimal timing for antihypertensive dosing: focus on valsartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Circadian variation and triggers of onset of acute cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Chronobiology and chronotherapeutics. Applications to cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Does dosing antihypertensive drugs at night alter renal or cardiovascular outcome: do we have the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Dosing time-dependent effect of trandolapril on the prevention of cardiac hypertrophy in rats with aortic banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Compliance with antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Comparison of the Efficacy of Morning versus Evening Administration of Olmesartan in Uncomplicated Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Antihypertensive efficacy of a single bedtime dose of methyldopa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Chronopharmacology of enalapril in hypertensive patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

The circadian heart rate but not blood pressure profile is influenced by the timing of beta-blocker administration in hypertensives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: relation to arising time

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Verapamil Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Administration-time dependent effects of acetyl-salicylic acid on blood pressure in patients with mild essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Determinants and consequences of the diurnal rhythm of blood pressure.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Use of a microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

[Chronotherapy with torasemide in hypertensive patients: increased efficacy and therapeutic coverage with bedtime administration]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Clinical benefits versus shortcomings of diltiazem once-daily in the chronotherapy of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021

Influence of aspirin usage on blood pressure: dose and administration-time dependencies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004184.PUB2

7 January 2021